Valuation: UNIL HEALNPV

Market Cap 43.57M 50.96M 6.5M 5.63M 5.32M 4.83M 9.05M 623M 9.11M 63.51M 24.54M 316M 24.4M 23.86M 1.01B P/E 2024
110x
P/E 2025 -3.29x
Enterprise Value 54.71M 63.99M 8.16M 7.07M 6.68M 6.07M 11.37M 782M 11.44M 79.76M 30.82M 397M 30.64M 29.96M 1.27B EV / Sales 2024
0.08x
EV / Sales 2025 0.14x
Free-Float
90.52%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 55 2012-03-11
Director of Finance/CFO 58 2011-09-30
Corporate Secretary - 2023-09-27
Director TitleAgeSince
Director/Board Member 53 2012-03-11
Director/Board Member 79 2013-11-17
Director/Board Member 80 2013-11-17
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 9.86M
-1.44%-6.28%-50.72%-17.35% 14.15B
-1.54%-4.13%-19.78%-11.15% 6.43B
-0.34%-7.17%-58.00%-37.71% 6.03B
-0.26%-0.13%-12.57%-20.78% 4.09B
+0.61%-2.21%-18.37%-38.94% 3.13B
-0.87%-0.11%+5.38%-29.71% 3.12B
-3.23%+7.55%+71.18% - 3.04B
+1.40%-3.43%-47.89%-27.14% 2.72B
-1.45%-1.17%-19.18%-8.39% 2.44B
Average -0.72%-0.26%-16.66%-23.90% 5.02B
Weighted average by Cap. -0.97%-1.81%-27.62%-22.28%

Financials

2024 2025
Net sales 1.09B 1.27B 162M 141M 133M 121M 226M 15.58B 228M 1.59B 613M 7.9B 610M 596M 25.18B 712M 832M 106M 91.93M 86.89M 78.88M 148M 10.18B 149M 1.04B 401M 5.16B 398M 390M 16.45B
Net income 413K 483K 61.57K 53.36K 50.43K 45.79K 85.81K 5.91M 86.33K 602K 233K 3M 231K 226K 9.55M -26.01M -30.42M -3.88M -3.36M -3.18M -2.88M -5.4M -372M -5.44M -37.91M -14.65M -189M -14.56M -14.24M -601M
Net Debt 33.68M 39.39M 5.02M 4.35M 4.11M 3.73M 7M 482M 7.04M 49.09M 18.97M 244M 18.86M 18.44M 779M 11.14M 13.03M 1.66M 1.44M 1.36M 1.24M 2.31M 159M 2.33M 16.24M 6.28M 80.82M 6.24M 6.1M 258M
Logo UNIL HEALNPV
Universal Health International Group Holding Ltd is an investment holding primarily engaged in the distribution and retail of drugs, healthcare products and other pharmaceutical products. The Company operates its businesses through three segments. The Distribution segment is primarily engaged in the distribution of drugs and other pharmaceutical products to pharmaceutical retailers, hospitals, clinics and distributors. The Retail segment is primarily engaged in the retail of drugs and other pharmaceutical products through a chain of retail pharmacies. The Others segment is primarily engaged in investment business. The Company’s products primarily include prescribed drugs, non-prescribed drugs, healthcare products and other pharmaceutical products. The Company primarily operates its businesses in the domestic market.
Employees
665
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!